# Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury

> **NCT03070353** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ramathibodi Hospital** · enrollment: 10 (actual)

## Conditions studied

- Cirrhosis, Liver
- AKI

## Interventions

- **DRUG:** Dextran 40

## Key facts

- **NCT ID:** NCT03070353
- **Lead sponsor:** Ramathibodi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2016-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070353, "Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03070353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*